Shigeyuki Itamura - Concepedia

Author

Shigeyuki Itamura

National Institute of Infectious Diseases

Also Known As

Itamura Shigeyuki, S Itamura, S. Itamura, Shigeyuki Itamura

Publications

Citations

H-Index

Concepts

All Affiliations

National Institute of Infectious Diseases Hokkaido University Tokyo University of Science Queen Mary Hospital University of Hong Kong

About

Shigeyuki Itamura is an author at National Institute of Infectious Diseases specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	1.5K
2	Allergy	3	3	53
3	Natural Sciences	2	2	181
4	Public Health	1	1	104
5	Biology	1	1	19

Shigeyuki Itamura

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques Bart L. Haagmans, Thijs Kuiken, B Martina, Nature Medicine Interferon-α ProtectsImmunologyViral PathogenesisImmunodominanceVirology	2004	387
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus S Li, Jerome L. Schulman, Shigeyuki Itamura, Journal of Virology Synthetic VirologyViral PathogenesisImmunologyGlycobiologyMolecular Biology	1993	162
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein Shuetsu Fukushi, Tetsuya Mizutani, Masayuki Saijo, Journal of General Virology Membrane FusionVirus StructureSynthetic VirologyRespiratory DiseasesSingle Spike	2005	152
Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine Takeshi Ichinohe, Shinichi Tamura, Akira Kawaguchi, The Journal of Infectious Diseases	2007	117
WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013 Ian Barr, Colin A. Russell, Terry G. Besselaar, Vaccine Virus EpidemiologyStrain SelectionFlu VaccinationGenetic CharacteristicsInfluenza Vaccines	2014	104
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge Takeshi Ichinohe, Akira Kawaguchi, Shinichi Tamura, Microbes and Infection VaccinationMucosal VaccinationVaccine DevelopmentPoly C12uHeterologous Virus Challenge	2007	96
Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection Hidekazu Nishimura, Shigeyuki Itamura, Takuya Iwasaki, Journal of General Virology	2000	94
Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic Ayato Takada, Noritaka Kuboki, Katsunori Okazaki, Journal of Virology	1999	90
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011 Alexander Klimov, Rebecca Garten, Colin A. Russell, Vaccine VaccinationVaccine DevelopmentVaccine TargetSeptember 2011Virology	2012	74
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection Yasuko Asahi‐Ozaki, Shigeyuki Itamura, Takeshi Ichinohe, Microbes and Infection VaccinationIntranasal AdministrationCross-protectionVaccine DevelopmentImmunology	2006	60

Page 1